Víctor S. Rangel: Advanced Endovascular Management in Severe Postpartum CVST
Víctor S. Rangel, Obstetrician-gynecologist and Career Researcher at Women’s Institute, Méderi, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Frontiers in Reproductive Health, adding:
“I am pleased to share our latest publication in Frontiers in Reproductive Health:
‘Endovascular mechanical thrombectomy for the treatment of extensive postpartum cerebral venous sinus thrombosis: a case report.’
This work highlights the continued progress of the Women’s Institute at Hospital Universitario Mayor-Méderi in the multidisciplinary management of critically ill obstetric patients and complex maternal conditions.
The case illustrates how timely multidisciplinary decision-making and advanced endovascular management can contribute to favorable outcomes in severe postpartum cerebral venous sinus thrombosis, with complete neurological recovery documented at six-month follow-up.
This publication also reflects our commitment to integrating high-complexity clinical care, multidisciplinary collaboration, and clinical research to generate evidence and improve maternal outcomes.
Congratulations to the entire clinical and research team involved in this work.”
Title: Endovascular mechanical thrombectomy for the treatment of extensive postpartum cerebral venous sinus thrombosis: a case report
Authors: Mariana Acosta Chiquillo, Rafael Leonardo Aragón Mendoza, Andrés Contreras, María Lucia Suárez Benítez, Víctor S. Rangel, Angela María Muñoz, Jorge L. Campo, Jose Alejandro Flórez Cardona
Stay updated with on all scientific advances Hemostasis Today.
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC